TOLAZAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tolazamide, and when can generic versions of Tolazamide launch?
Tolazamide is a drug marketed by Barr, Chartwell Rx, Cosette, Duramed Pharms Barr, Interpharm, Mylan Pharms Inc, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, and Watson Labs. and is included in thirty NDAs.
The generic ingredient in TOLAZAMIDE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
Summary for TOLAZAMIDE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 30 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 4,134 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOLAZAMIDE at DailyMed |
Recent Clinical Trials for TOLAZAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) | |
Canadian Network for Observational Drug Effect Studies, CNODES |